Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008
Curemark announced today that it has been chosen to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, 2008 to be held in New York City. Rye, NY (PRWEB) October 29, 2008 -- Curemark (www.cure-mark.com) announced today that it has been chosen to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, 2008 to be held in New York City.
The 2008 Life Sciences and Healthcare Venture Summit presented by Young Startup Ventures is the premier bioscience industry gathering, connecting senior executives of the early stage biotech, pharmaceutical, healthcare, medical device and diagnostic companies with venture capitalists, angel investors, corporate VCs and professional service firms.
Sponsored by such important industry leaders as Pillsbury, KPMG, New York City Bioscience Initiative, ADP, Cooley Godward Kronish, Morgan Lewis, Young Startup Ventures and Intel Capital, the Summit organizers state that the Summit features 40 of the "hottest emerging companies".
"The Summit is considered to be the premier bioscience industry gathering," states Curemark CEO Dr. Joan Fallon. " We are honored to have been chosen to present at this prestigious event."
About Curemark
Curemark is a biotechnology company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon. The company is currently preparing for clinical trials. To learn more about our innovative science, please visit: www.cure-mark.com.
###
Simillar Articles
 | | Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford |
| Curemark, LLC announced today that Founder and CEO Dr. Joan Fallon has presented Curemark's most recent findings on autism at the Gordon Conference on Neurobiology and Brain Disorders which... |
|
| | Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations |
| Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately. |
|
| | DeSilva+Phillips, Media Investment Bankers, Announces 'October 2007 Healthcare Media M&A... |
| DeSilva + Phillips, media investment bankers, announces a major conference on deal-making in the healthcare communications and information market -- The DeSilva + Phillips Healthcare Media M&A... |
|
| | PharmaVentures and Growthink Research Join Forces to Deliver Bioscience Industry Information... |
| PharmaVentures has announced its agreement with Growthink Research, the US-based market research company, to distribute the Growthink Research Venture Capital database to PharmaVentures'... |
|
| | M.D. Venture Partners Announces $5 Million Dollar Equity Investment in ProstimRx Corporation |
| M.D. Venture Partners, a healthcare technology venture capital firm, is pleased to announce an equity investment of $5 million dollars into ProstimRx Corporation of Hendersonville, Tennessee. |
|
|
